ES8706029A1 - Un procedimiento para la preparacion de una composicion antiacida de alginato de magnesio. - Google Patents

Un procedimiento para la preparacion de una composicion antiacida de alginato de magnesio.

Info

Publication number
ES8706029A1
ES8706029A1 ES542430A ES542430A ES8706029A1 ES 8706029 A1 ES8706029 A1 ES 8706029A1 ES 542430 A ES542430 A ES 542430A ES 542430 A ES542430 A ES 542430A ES 8706029 A1 ES8706029 A1 ES 8706029A1
Authority
ES
Spain
Prior art keywords
antacid composition
antacid
composition
treatment
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES542430A
Other languages
English (en)
Other versions
ES542430A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rorer International Overseas Inc
Original Assignee
Rorer International Overseas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rorer International Overseas Inc filed Critical Rorer International Overseas Inc
Publication of ES542430A0 publication Critical patent/ES542430A0/es
Publication of ES8706029A1 publication Critical patent/ES8706029A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR UNA COMPOSICION ANTIACIDA DE ALGINATO DE MAGNESIO. CONSISTE EN TAMIZAR EL ALGINATO DE MAGNESIO, EL ANTIACIDO Y DEMAS COMPONENTES OPCIONALES, PARA ELIMINAR LAS PARTICULAS GRANDES; COLOCAR LOS INGREDIENTES TAMIZADOS EN UN MEZCLADOR ADECUADO Y MEZCLARLOS; HUMEDECER EL GRANULADO MEZCLADO RESULTANTE CON AGUA DESIONIZADA Y COLOCARLO EN BANDEJAS APROPIADAS, EN UNA ESTUFA PARA SECARLO AL NIVEL DE HUMEDAD ADECUADA; MOLER EL GRANULADO SECO A TRAVES DE UN TAMIZ APROPIADO; Y FINALMENTE COMPRIMIR EL PRODUCTO OBTENIDO EN TABLETAS. TIENE APLICACIONES FARMACEUTICAS PARA EL TRATAMIENTO DE LA ESOFAGUITIS DE REFLUJO.
ES542430A 1984-04-19 1985-04-19 Un procedimiento para la preparacion de una composicion antiacida de alginato de magnesio. Expired ES8706029A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60179684A 1984-04-19 1984-04-19

Publications (2)

Publication Number Publication Date
ES542430A0 ES542430A0 (es) 1987-06-01
ES8706029A1 true ES8706029A1 (es) 1987-06-01

Family

ID=24408805

Family Applications (1)

Application Number Title Priority Date Filing Date
ES542430A Expired ES8706029A1 (es) 1984-04-19 1985-04-19 Un procedimiento para la preparacion de una composicion antiacida de alginato de magnesio.

Country Status (11)

Country Link
EP (1) EP0179858B1 (es)
JP (1) JPH0764737B2 (es)
KR (1) KR850007561A (es)
CN (1) CN85104754A (es)
AT (1) ATE77750T1 (es)
AU (1) AU578690B2 (es)
CA (1) CA1259916A (es)
DE (1) DE3586281T2 (es)
ES (1) ES8706029A1 (es)
FR (1) FR2563108B1 (es)
WO (1) WO1985004806A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744986A (en) * 1986-03-07 1988-05-17 Rorer Pharmaceutical Corporation Process for the preparation of a viscosity-stable antacid composition
DE3612086A1 (de) * 1986-04-10 1987-10-15 Bayer Ag Konservierte antacida-zubereitungen
DK179687D0 (da) * 1987-04-08 1987-04-08 Farma Food As Praeparat
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
US5360793A (en) * 1993-05-24 1994-11-01 Sterling Winthrop Inc. Rafting antacid formulation
GB9504599D0 (en) * 1995-03-03 1995-04-26 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
WO1998014198A1 (en) * 1996-10-04 1998-04-09 Merck & Co., Inc. Methods and compositions for preventing and treating heartburn
US6395307B1 (en) * 1997-04-30 2002-05-28 Reckitt Benckiser (Uk) Limited Pourable alginate compositions
AU2002356493A1 (en) * 2001-11-19 2003-06-10 Nobel Ilac Sanayii Ve Ticaret A.S. New pharmaceutical combinations prepared with alginates and biphosphonates in order to prevent gastroesophageal reflux during use of oral biphoshonates
WO2005018613A1 (de) * 2003-08-26 2005-03-03 Mandapro Ag Pellets für die orale applikation von pharmazeutischen wirkstoffen
DE102006037298A1 (de) 2006-08-08 2008-02-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung, insbesondere Antazidum
IT1406155B1 (it) * 2011-02-22 2014-02-14 Rossi Composizioni di alginato di magnesio e derivati come adiuvanti nel trattamento del reflusso gastrico
LT2806880T (lt) 2012-01-27 2017-08-25 Institute Of Bioorganic Chemistry Farmacinė kompozicija, kaip substancija antacidiniam vaistui nuo refliukso
CN104688765A (zh) * 2013-12-04 2015-06-10 博晖(大连)实业有限公司 一种由海藻酸盐组合的组方胃药
IT202100000059A1 (it) * 2021-01-04 2022-07-04 Nyuma Pharma Srl Nuove composizioni di sucralfato in alginato e loro utilizzo in terapia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1363399A (en) * 1972-04-13 1974-08-14 Rotta Research Lab Method of preparing an antacid pharmaceutical product
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
GB1598375A (en) * 1978-02-17 1981-09-16 Anphar Sa Aluminium magnesium carbonate

Also Published As

Publication number Publication date
ES542430A0 (es) 1987-06-01
FR2563108B1 (fr) 1987-09-04
EP0179858A1 (en) 1986-05-07
AU4233685A (en) 1985-11-15
KR850007561A (ko) 1985-12-07
WO1985004806A1 (en) 1985-11-07
JPH0764737B2 (ja) 1995-07-12
ATE77750T1 (de) 1992-07-15
AU578690B2 (en) 1988-11-03
DE3586281D1 (de) 1992-08-06
CA1259916A (en) 1989-09-26
JPS61501916A (ja) 1986-09-04
DE3586281T2 (de) 1992-12-10
EP0179858B1 (en) 1992-07-01
FR2563108A1 (fr) 1985-10-25
EP0179858A4 (en) 1986-09-15
CN85104754A (zh) 1986-12-10

Similar Documents

Publication Publication Date Title
EP0287817A3 (en) Photopolymerisable composition and registration material prepared therewith
EP0284938A3 (en) Photopolymerisable composition and registration material prepared therewith
EP0290207A3 (en) Orthopedic casting materials and methods
NZ224272A (en) Pharmaceutical composition containing 17-ketosteroid and an immunomodulator
JPS6445468A (en) Storage-stable and thermosettable organosiloxane composition
EP0494704A3 (en) Method and composition for the determination of calcium ions in fluids
ZA883408B (en) Superabsorbent composition and process
DE3853340D1 (de) Dien-Blockpolymer und Polymerzusammensetzung.
AR245000A1 (es) Un metodo para preparar composiciones fibrinoliticas mejoradas.
ES8706029A1 (es) Un procedimiento para la preparacion de una composicion antiacida de alginato de magnesio.
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
NZ226450A (en) Crystalline-1-carbacephalosporin and pharmaceutical compositions
EP0304802A3 (en) Pharmaceutical composition and the use thereof
AU1114388A (en) Anesthetic composition and method of using the same
AP9000161A0 (en) Insecticidal treatment and composition therefor
JPS6452642A (en) Hydraulic cement mixture and manufacture
ZA897692B (en) Triglycerides,composition comprising such triglycerides,and use of such composition
AU1279188A (en) Cement composition and use thereof
EP0437026A3 (en) Use of tandospirone in the treatment of depression
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
JPS6466146A (en) Fluorobenzyl ester, manufacture and insecticidal composition
GB2166665B (en) Refractory laminate composition and process
EP0307665A3 (en) Encapsulation composition and use thereof
JPS56140923A (en) Nutrient composition and administration thereof
ZA888097B (en) Phthalazineacetic acid composition and tablet

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070319